Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015958224> ?p ?o ?g. }
- W3015958224 endingPage "1783" @default.
- W3015958224 startingPage "1769" @default.
- W3015958224 abstract "Atherosclerosis (AS) is the leading cause of heart attacks, stroke, and peripheral vascular disease. Berberine (BBR), a botanical medicine, has diversified anti-atherosclerotic effects but with poor absorption. The aim of this study was to develop an effective BBR-entrapped nano-system for treating AS in high-fat diet (HFD)-fed Apoe(−/−) mice, and also explore the possible underlying mechanisms involved. Three d-α-tocopherol polyethylene glycol (PEG) succinate (TPGS) analogues with different PEG chain lengths were synthesized to formulate BBR-entrapped micelles. HFD-fed Apoe(−/−) mice were administered with optimized formula (BBR, 100 mg/kg/day) orally for 5 months. The artery plaque onset and related metabolic disorders were evaluated, and the underlying mechanisms were studied. Our data showed that, BT1500M increased BBR deposition in liver and adipose by 107.6% and 172.3%, respectively. In the Apoe(−/−) mice, BT1500M ameliorated HFD-induced hyperlipidemia and lipid accumulation in liver and adipose. BT1500M also suppressed HFD-induced chronic inflammation as evidenced by the reduced liver and adipose levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β); and decreased plasma level of TNF-α, IL-6, IL-1β, interferon-γ (IFN-γ), monocyte chemotactic protein (MCP), and macrophage inflammatory factor (MIP). The mechanism study showed that BT1500M changed Ampk and Nf-κb gene expression, and interrupted a crosstalk process between adipocytes and macrophages. Further investigation proved that BT1500M decreased endothelial lesion and subsequent macrophage activation, cytokines release, as well as cholesteryl ester gathering in the aortic arch, resulting in ameliorated artery plaque build-up. Our results provide a practical strategy for treating AS using a BBR-entrapped nano-system." @default.
- W3015958224 created "2020-04-17" @default.
- W3015958224 creator A5003947656 @default.
- W3015958224 creator A5008008825 @default.
- W3015958224 creator A5016287957 @default.
- W3015958224 creator A5018120077 @default.
- W3015958224 creator A5022526821 @default.
- W3015958224 creator A5036805693 @default.
- W3015958224 creator A5040166779 @default.
- W3015958224 creator A5048487107 @default.
- W3015958224 creator A5056140696 @default.
- W3015958224 creator A5061811574 @default.
- W3015958224 creator A5079144123 @default.
- W3015958224 creator A5081675173 @default.
- W3015958224 creator A5082151127 @default.
- W3015958224 creator A5084821441 @default.
- W3015958224 date "2020-09-01" @default.
- W3015958224 modified "2023-10-18" @default.
- W3015958224 title "Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe() mice" @default.
- W3015958224 cites W1256084377 @default.
- W3015958224 cites W1920804658 @default.
- W3015958224 cites W1966163938 @default.
- W3015958224 cites W1969395627 @default.
- W3015958224 cites W1970205234 @default.
- W3015958224 cites W1975825141 @default.
- W3015958224 cites W1991274029 @default.
- W3015958224 cites W1992007939 @default.
- W3015958224 cites W1994174603 @default.
- W3015958224 cites W1998007192 @default.
- W3015958224 cites W1998710183 @default.
- W3015958224 cites W2015621850 @default.
- W3015958224 cites W2034134526 @default.
- W3015958224 cites W2037192290 @default.
- W3015958224 cites W2037275677 @default.
- W3015958224 cites W2038231515 @default.
- W3015958224 cites W2044115042 @default.
- W3015958224 cites W2046785634 @default.
- W3015958224 cites W2059617501 @default.
- W3015958224 cites W2073882423 @default.
- W3015958224 cites W2074275151 @default.
- W3015958224 cites W2074697439 @default.
- W3015958224 cites W2077792952 @default.
- W3015958224 cites W2084273130 @default.
- W3015958224 cites W2086290312 @default.
- W3015958224 cites W2087343685 @default.
- W3015958224 cites W2101328621 @default.
- W3015958224 cites W2102785524 @default.
- W3015958224 cites W2103418921 @default.
- W3015958224 cites W2109127613 @default.
- W3015958224 cites W2114349736 @default.
- W3015958224 cites W2115586774 @default.
- W3015958224 cites W2115865708 @default.
- W3015958224 cites W2128571278 @default.
- W3015958224 cites W2130478732 @default.
- W3015958224 cites W2153439192 @default.
- W3015958224 cites W2184254448 @default.
- W3015958224 cites W2298702929 @default.
- W3015958224 cites W2509676484 @default.
- W3015958224 cites W2528199903 @default.
- W3015958224 cites W2580542494 @default.
- W3015958224 cites W2581464241 @default.
- W3015958224 cites W2594247592 @default.
- W3015958224 cites W2770717271 @default.
- W3015958224 cites W2791641807 @default.
- W3015958224 cites W2791817991 @default.
- W3015958224 cites W2897998556 @default.
- W3015958224 cites W2914972362 @default.
- W3015958224 cites W2921012991 @default.
- W3015958224 cites W2943201830 @default.
- W3015958224 cites W2969375616 @default.
- W3015958224 cites W2984766121 @default.
- W3015958224 cites W2996714785 @default.
- W3015958224 cites W4230869250 @default.
- W3015958224 cites W66407225 @default.
- W3015958224 cites W949053941 @default.
- W3015958224 doi "https://doi.org/10.1016/j.apsb.2020.03.005" @default.
- W3015958224 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7564017" @default.
- W3015958224 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33088695" @default.
- W3015958224 hasPublicationYear "2020" @default.
- W3015958224 type Work @default.
- W3015958224 sameAs 3015958224 @default.
- W3015958224 citedByCount "24" @default.
- W3015958224 countsByYear W30159582242021 @default.
- W3015958224 countsByYear W30159582242022 @default.
- W3015958224 countsByYear W30159582242023 @default.
- W3015958224 crossrefType "journal-article" @default.
- W3015958224 hasAuthorship W3015958224A5003947656 @default.
- W3015958224 hasAuthorship W3015958224A5008008825 @default.
- W3015958224 hasAuthorship W3015958224A5016287957 @default.
- W3015958224 hasAuthorship W3015958224A5018120077 @default.
- W3015958224 hasAuthorship W3015958224A5022526821 @default.
- W3015958224 hasAuthorship W3015958224A5036805693 @default.
- W3015958224 hasAuthorship W3015958224A5040166779 @default.
- W3015958224 hasAuthorship W3015958224A5048487107 @default.
- W3015958224 hasAuthorship W3015958224A5056140696 @default.
- W3015958224 hasAuthorship W3015958224A5061811574 @default.
- W3015958224 hasAuthorship W3015958224A5079144123 @default.
- W3015958224 hasAuthorship W3015958224A5081675173 @default.